ERIKA VANCE: Open Payments
NPI 1366816670 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,050 in 132 payments from 19 companies in 2025. Trend: 2023 $2,189 · 2024 $2,207 · 2025 $2,050
Food & beverage: $2,050
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 29 | $358 |
| ABBVIE INC. | 26 | $309 |
| Otsuka America Pharmaceutical, Inc. | 14 | $271 |
| AstraZeneca Pharmaceuticals LP | 9 | $262 |
| Lilly USA, LLC | 19 | $207 |
| Astellas Pharma US Inc | 4 | $105 |
| Novo Nordisk Inc | 6 | $96 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $79 |
| Lundbeck LLC | 3 | $74 |
| Medtronic, Inc. | 2 | $55 |
Products named: REXULTI, NURTEC ODT, AIRSUPRA, UBRELVY, MOUNJARO, Veozah, ELIQUIS, Kerendia.
Industry payments across AR — which companies pay providers there.
